|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09997 KANGJI MEDICAL
Nominal 
8.890 +0.020 (+0.225%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 496,555 | 8.320% | 458,413 | 403,589 | 332,321 | 318,124 |
| Cost of Sales | (104,194) | 9.344% | (95,290) | (81,834) | (66,609) | (56,897) |
| Gross Profit | 392,361 | 8.052% | 363,123 | 321,755 | 265,712 | 261,227 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (1,337) | -- | 842 | (1,647) | (639) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (19,542) | 233.027% | (5,868) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 324,876 | -0.872% | 327,733 | 271,282 | 194,794 | 234,349 | |
| Taxation | (59,116) | 13.582% | (52,047) | (41,985) | (41,297) | (34,991) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 10,161 | 26,164 | 4,216 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 265,760 | -7.027% | 285,847 | 255,461 | 157,713 | 199,358 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (21,185) | -65.839% | (62,016) | (41,459) | (25,815) | (14,536) |
| Depreciation & Amortisation | 16,010 | 12.913% | 14,179 | 16,162 | 8,939 | 5,524 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 22.560 | -7.503% | 24.390 | 21.830 | 12.950 | 16.270 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.148 | -- | 1.945 | 2.796 | 2.665 | 2.454 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 265,760 |
| %Change | -7.027% |
| EPS / (LPS) | RMB 0.226 |
| NBV Per Share (¥) | RMB 2.148 |